1. Atsuta N, Watanabe H, Ito M et al (2011) Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and applica- tion of this system in a longitudinal multicenter study. Shinkei Kenkyu No Shinpo 63:491–496
2. Watanabe H, Atsuta N, Hirakawa A et al (2016) A rapid func- tional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. J Neurol Neurosurg Psychiatry 87:851–858
3. Chiò A, Mora G, Leone M et al (2002) Early symptom progres- sion rate is related to ALS outcome: a prospective population- based study. Neurology 59:99–103
4. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM (2000) Clinical features of amyotrophic lateral sclerosis accord- ing to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol 57:1171–1176
5. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60:813–819
6. Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A (2005) Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 25:114–119
7. Chio A, Logroscino G, Hardiman O et al (2009) Prognostic factors in ALS: a critical review. Amyotrophic Lateral Scler 10:310–323
8. Ning P, Yang B, Li S et al (2019) Systematic review of the prog- nostic role of body mass index in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 20:356–367
9. Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265–267
10. Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Moham- madi B (2008) ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci 275:69–73
11. Lanznaster D, Bejan-Angoulvant T, Patin F et al (2019) Plasma creatinine and amyotrophic lateral sclerosis prognosis: a sys- tematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener 20:199–206
12. Ikenaka K, Atsuta N, Maeda Y et al (2019) Increase of arginine dimethylation correlates with the progression and prognosis of ALS. Neurology 92:e1868–e1877
13. Roche JC, Rojas-Garcia R, Scott KM et al (2012) A proposed stag- ing system for amyotrophic lateral sclerosis. Brain 135:847–852
14. Chiò A, Hammond ER, Mora G et al (2015) Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 86:38–44
15. Tramacere I, Della Bella E, Chiò A et al (2015) The MITOS system predicts long-term survival in amyotrophic lateral scle- rosis. J Neurol Neurosurg Psychiatry 86:1180–1185
16. Pinto S, de Carvalho M (2017) Comparison of slow and forced vital capacities on ability to predict survival in ALS. Amyotroph Lateral Scler and Frontotemporal Degener 18:528–533
17. Watanabe H, Atsuta N, Nakamura R et al (2015) Factors affect- ing longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotem- poral Degener 16:230–236
18. Hama T, Hirayama M, Hara T et al (2012) Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials. Muscle Nerve 45:169–174
19. Ohashi Y, Tashiro K, Itoyama Y et al (2001) Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS (ALSFRS-R) Japanese version. No To Shinkei 53:346–355
20. Kimura J (2001) Electrodiagnosis in diseases of nerve and mus- cle: principles and practice, 3rd edn. Oxford University Press, New York, pp 130–177
21. Koike H, Mori K, Misu K et al (2001) Painful alcoholic poly- neuropathy with predominant small-fiber loss and normal thia- mine status. Neurology 56:1727–1732
22. Suzuki K, Katsuno M, Banno H et al (2008) CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain 131:229–239
23. American Association of Electrodiagnostic Medicine, Ameri- can Academy of Neurology, and American Academy of Physi- cal Medicine and Rehabilitation (2002) Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement. Muscle Nerve 25:918–922
24. Kano O, Iwamoto K, Ito H et al (2013) Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset. BMC Neurol 13:19
25. Kihira T, Yoshida S, Okamoto K et al (2008) Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Pre- fecture, Japan, 1966 to 2005. J Neurol Sci 268:95–101
26. Shin JO (1993) Clinical electromyography: nerve conduction studies, 3rd edn. Williams and Wilkins, Baltimore, pp 582–600
27. Bradley WG, Good P, Rasool CG, Adelman LS (1983) Morpho- metric and biochemical studies of peripheral nerves in amyo- trophic lateral sclerosis. Ann Neurol 14:267–277
28. Kawamura Y, Dyck PJ, Shimono M, Okazaki H, Tateishi J, Doi H (1981) Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 40:667–675
29. Wilbourn AJ (2000) The “split hand syndrome”. Muscle Nerve 23:138
30. Kuwabara S, Sonoo M, Komori T et al (2008) Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve 37:426–430
31. Eisen A, Kuwabara S (2012) The split hand syndrome in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 83:399–403
32. Behse F (1978) Sensory action potentials and biopsy of the sural nerve in neuropathy. Brain 101:473–493
33. Hammad M, Silva A, Glass J, Sladky JT, Benatar M (2007) Clinical, electrophysiologic, and pathologic evidence for sen- sory abnormalities in ALS. Neurology 69:2236–2242
34. Pugdahl K, Fuglsang-Frederiksen A, de Carvalho M et al (2007) Generalised sensory system abnormalities in amyotrophic lat- eral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry 78:746–749
35. Isak B, Tankisi H, Johnsen B et al (2016) Involvement of distal sensory nerves in amyotrophic lateral sclerosis. Muscle Nerve 54:1086–1092
36. Truini A, Biasiotta A, Onesti E et al (2015) Small-fibre neuropa- thy related to bulbar and spinal-onset in patients with ALS. J Neurol 262:1014–101837. Dalla Bella E, Lombardi R, Porretta-Serapiglia C et al (2016) Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol 23:416–420
38. Taylor PK (1993) CMAP dispersion, amplitude decay, and area decay in a normal population. Muscle Nerve 16:1181–1187
39. Martínez-Silva ML, Imhoff-Manuel RD, Sharma A et al (2018) Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS. Elife 7:e30955
40. Kanai K, Shibuya K, Sato Y et al (2012) Motor axonal excitabil- ity properties are strong predictors for survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 83:734–738
41. Sangari S, Iglesias C, El Mendili MM et al (2016) Impairment of sensory-motor integration at spinal level in amyotrophic lateral sclerosis. Clin Neurophysiol 127:1968–1977
42. Kieran D, Hafezparast M, Bohnert S et al (2005) A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol 169:561–567
43. Ilieva HS, Yamanaka K, Malkmus S et al (2008) Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc Natl Acad Sci USA 105:12599–12604
44. Nakamura R, Sone J, Atsuta N et al (2016) Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging 39:219.e1–8
45. Swash M, de Carvalho M (2019) The ’neurophysiological index’ predicts survival in amyotrophic lateral sclerosis. Clin Neuro- physiol 130:1684–1685